Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cabal

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2025
A QSP PDE model of ADC transport and kinetics in a growing or shrinking tumorDavid S Ross, Antonio Cabal
Bulletin of Mathematical Biology|December 2, 2016
Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various TherapiesDavid S Ross, Khamir Mehta, Antonio Cabal
Bone Reports|April 6, 2017
Long-term treatment with odanacatib maintains normal trabecular biomechanical properties in ovariectomized adult monkeys as demonstrated by micro-CT-based finite element analysisAntonio Cabal, Donald S Williams, Richa Y Jayakar, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 26, 2013
A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humansAntonio Cabal, Khamir Mehta, David S Ross, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's diseaseHugo Geerts, Mike Walker, Rachel Rose, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strengthAngela M Cheung, Sharmila Majumdar, Kim Brixen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspectivePeter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, et al.
Molecular Pharmaceutics|May 24, 2022
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product AttributesPer Bäckman, Antonio Cabal, Andy Clark, et al.
Molecular Pharmaceutics|May 16, 2022
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification SystemJayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Bone|April 4, 2012
Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkeyRicha Y Jayakar, Antonio Cabal, John Szumiloski, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2025
A QSP PDE model of ADC transport and kinetics in a growing or shrinking tumorDavid S Ross, Antonio Cabal
Bulletin of Mathematical Biology|December 2, 2016
Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various TherapiesDavid S Ross, Khamir Mehta, Antonio Cabal
Bone Reports|April 6, 2017
Long-term treatment with odanacatib maintains normal trabecular biomechanical properties in ovariectomized adult monkeys as demonstrated by micro-CT-based finite element analysisAntonio Cabal, Donald S Williams, Richa Y Jayakar, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 26, 2013
A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humansAntonio Cabal, Khamir Mehta, David S Ross, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's diseaseHugo Geerts, Mike Walker, Rachel Rose, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strengthAngela M Cheung, Sharmila Majumdar, Kim Brixen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspectivePeter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, et al.
Molecular Pharmaceutics|May 24, 2022
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product AttributesPer Bäckman, Antonio Cabal, Andy Clark, et al.
Molecular Pharmaceutics|May 16, 2022
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification SystemJayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Bone|April 4, 2012
Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkeyRicha Y Jayakar, Antonio Cabal, John Szumiloski, et al.
Pageof 2